The automated PCR test provides results in 20 minutes to help clinicians diagnose common causes of vaginitis during a patient visit.
FIRST OF THREE STEPS TOWARD BRINGING NOVEL RADIOISOTOPE PRODUCTION PLATFORM ONLINE
Novel gel embolic designed to give physicians greater control and consistency during embolization.
SINTX’s advanced ceramic manufacturing platform supports customers across multiple industries requiring high-performance materials.
Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
AI-powered voice analysis is now available to clinicians directly inside Zoom, transforming routine telehealth conversations into early signals for behavioral and cognitive health
The designation follows encouraging Phase 2 clinical trial results.
Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases.
Visit has included tour of Utah headquarters and automated manufacturing facilities ahead of planned technology transfer.
First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organs.
The study, published in the Journal of Arthroplasty, highlighted that the Company’s NeuroCuple® Nanotechnology Device achieved statistically significant reduction in opioid use.